Everence Capital Management Inc Johnson & Johnson Transaction History

Everence Capital Management Inc

$1.59 Billion
Q3 2024

A detailed history of Everence Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Everence Capital Management Inc holds 73,341 shares of JNJ stock, worth $10.6 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

73,341

Previous 70,781 3.62%

Holding current value

$10.6 Million

Previous $10.2 Million 16.14%

% of portfolio

0.75%

Previous 0.71%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$145.48 - $167.38 $372,428 - $428,492	2,560 Added 3.62%	73,341 $11.9 Million
Q4 2023 Jan 30, 2024	BUY	$145.6 - $158.88 $846,227 - $923,410	5,812 Added 8.95%	70,781 $11.1 Million
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $1.1 Million - $1.24 Million	-7,090 Reduced 9.84%	64,969 $10.1 Million
Q1 2023 Apr 04, 2023	BUY	$151.05 - $180.26 $283,974 - $338,888	1,880 Added 2.68%	72,059 $11.2 Million
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $145,782 - $163,608	910 Added 1.31%	70,179 $12.4 Million
Q1 2022 Apr 11, 2022	SELL	$158.14 - $179.59 $22,139 - $25,142	-140 Reduced 0.2%	69,269 $12.3 Million
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $1.44 Million - $1.6 Million	9,230 Added 15.34%	69,409 $11.9 Million
Q4 2020 Feb 01, 2021	SELL	$137.11 - $157.38 $900,812 - $1.03 Million	-6,570 Reduced 9.84%	60,179 $9.47 Million
Q3 2020 Feb 01, 2021	SELL	$140.38 - $153.83 $1.03 Million - $1.13 Million	-7,350 Reduced 9.92%	66,749 $9.94 Million
Q4 2019 Jan 28, 2020	BUY	$127.5 - $146.44 $936,870 - $1.08 Million	7,348 Added 11.01%	74,099 $10.8 Million
Q2 2019 Aug 02, 2019	BUY	$131.15 - $144.24 $205,905 - $226,456	1,570 Added 2.41%	66,751 $9.3 Million
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $1.09 Million - $1.21 Million	8,679 Added 15.36%	65,181 $9.11 Million
Q2 2018 Jul 26, 2018	SELL	$119.4 - $131.76 $459,690 - $507,275	-3,850 Reduced 6.38%	56,502 $6.86 Million
Q1 2018 Apr 30, 2018	SELL	$125.1 - $148.14 $253,953 - $300,724	-2,030 Reduced 3.25%	60,352 $7.73 Million
Q4 2017 Feb 02, 2018	BUY	$131.22 - $143.62 $408,094 - $446,658	3,110 Added 5.25%	62,382 $8.72 Million
Q3 2017 Oct 31, 2017	BUY	$129.47 - $135.38 $7.67 Million - $8.02 Million	59,272	59,272 $7.71 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Johnson & Johnson Transaction History